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Aim To study the short tandem repeat (STR) pattern of 
DNA from the blood, buccal swabs, and hair follicles of the 
recipients of allogenic hematopoietic stem cell transplan-
tation to examine whether these tissues contain donor de-
rived cells.
Methods The study enrolled 25 patients who sustained 
engraftment. Peripheral blood, buccal swabs, and hair fol-
licles were collected on days 21-30, 90, and 180 after trans-
plantation and the chimeric status of the recipients was 
evaluated.
Results Donor derived cells existed in the blood and buc-
cal swabs, but not in hair follicles, which can be used to ob-
tain the pre-transplant sample of the recipient after trans-
plant.
Conclusion Peripheral blood and buccal swab do not 
serve as a reliable source of recipient’s origin for DNA anal-
ysis of individuals who underwent allogenic hematopoi-
etic stem cell transplantation at least within 6 months after 
transplant.
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Chimerism is an exceptional immunogenetic condition, 
characterized by the presence of cell populations origi-
nating from two different individuals. These cells could be 
derived from a fetal maternal transfusion, blood transfu-
sion, or after allo- hematopoietic stem cell transplantation 
(HSCT) or mobilized peripheral blood stem cell transplan-
tation (PBSCT) (1). BMT/PBSCT has been widely accepted 
as a convincing life-saving treatment modality for various 
malignant and non-malignant hematologic diseases. Chi-
merism analysis is an important tool for the pre-transplant 
surveillance of engraftment and offers the possibility to re-
alize impending graft acceptance or rejection (2). Besides 
clinical cases, it is also important in forensic analysis.
Polymorphic STR analysis is presently the most common 
analytical method employed for forensic identity testing 
(3), since it is more sensitive than analysis with any other 
polymorphic markers and allows unambiguous assign-
ment of alleles. Blood, buccal swabs, and hair follicles are 
among the most important and common biological sam-
ples used for DNA profiling as they carry high evidential 
value (4). However, these samples may lead to erroneous 
interpretations of results when the person being analyzed 
is a genetic chimera, since this condition has the potential 
to change the genetic makeup of the individuals.
Many studies showed that blood was not a suitable sub-
strate for personal identification due to the presence of do-
nor cells in the recipient blood cells (5,6). Along with blood, 
buccal swabs and saliva are also reported to show conver-
sion to donor type (7-12). Other commonly encountered 
biological sources for forensic DNA profiling, especially in 
rape cases, are fingernails and hair follicles. However, there 
were studies showing donor chimerism in these sources 
as well (13-16).
Various studies have been conducted using different mark-
ers to evaluate the percentage of donor derived cells in dif-
ferent biological samples of recipients but there is no clear 
indication about the informativity of STR markers used for 
forensic purpose in chimerism analysis. Thus, the aim of 
this study was to evaluate the chimeric level in recipient 
blood, buccal swabs, and hair follicles at different time in-
tervals after allo-BMT or PBSCT with the markers that are 
being extensively used in forensic DNA analysis.
MATeRiAls AnD MeThoDs
Twenty five patients who had received allo-HSCT or PB-
SCT for various hematological disorders were recruit-
ed in 2010 from the department of Haematology, All India 
Institute of Medical Sciences (Table 1). The present study 
was reviewed and approved by the ethics committee of this 
institute (IESC/T-302/2010 of Nov 2, 2010). Written consent 
was obtained from every participant prior to the sampling.
Donor and pre-transplant recipient’s blood samples were 
collected for the reference material. Pre-transplant buc-
cal swabs and hair follicles were collected to rule out the 
possibility of natural chimerism. All the peripheral blood 
samples from donors and recipients were collected in 
5-mL EDTA coated tubes. Buccal swabs from recipients 
were collected from the both sides of the oral cavity on 
cotton sticks and kept frozen until the DNA extraction. 
Before taking buccal swab samples, patients were coun-
selled to refrain from food and drink and maintain high 
level of oral hygiene, avoiding any possible contamina-
tion at least for one hour prior to the sampling. 5-8 hair 
strands along with root were plucked from the scalp. 
Presence of hair bulb was visually confirmed. Long hairs 
were cut to around 2 cm including the root, and distal 
parts were discarded.
Peripheral blood, buccal swabs, and hair follicles from the 
recipients were collected on days 21-30, 90, and 180 af-




Male 19  76.00
Female  6  24.00
number of samples
Buccal swab 75 samples
Blood 75 samples
Hair root 75 samples
Recipient /donor relationship
Related 25 100.00
Not related  0   0.00
sex match with donor 13  52.00
Sex mismatch with donor 12  48.00
Disease
Severe aplastic anemia 13  52.00
Thalassemia  6  24.00
Myelogenous leukemia (acute myeloid 
leukemia/chronic myeloidleukemia
 3  12.00
Acute mixed phenotypic leukemia  2   8.00
Red blood cell aplasia  1   4.00
origin of stem cells
Peripheral blood 18  72.00
Bone marrow  7  28.00
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ter transplantation. Genomic DNA from all the samples 
was isolated using organic extraction method (17). Qual-
ity and quantity of extracted genomic DNA was evaluated 
by agarose gel electrophoresis and UV spectrophotomety 
(Nanodrop, Thermospectronic, Rochester, NY, USA). Ampli-
fication of extracted DNA was carried out using AmpFlSTR 
identifiler kit (Applied Biosystems, Foster City, CA, USA), 
which co-amplifies 15 loci (D8S1179, D21S11, D7S820, 
CSFIPO, D3S1358, THO1, D135317, D16S539, D2S1338, 
D19S433, vWA, TPOX, D18S51, D5S818, FGA) and the sex 
determining marker, amelogenin. The amplified DNA was 
analyzed by ABI 3100 genetic analyzer and genotype soft-
ware version 3.2 (Applied Biosystems). Three controls (In-
built house kit and negative one) were used to maintain 
the sensitivity of the analysis. Donor chimerism was calcu-
lated according to peak area of the donor and the recipi-
ent allele (18). The chimerism percentage was calculated 
for every possible combination: type I – by considering 
only alleles not shared between recipient and donor; type 
II – by considering at least one shared and one unshared 
allele between recipient and donor; type III – by consider-
ing alleles common between recipient and donor. Type III 
was considered to be non- informative and was exclud-
ed from chimerism percentage calculation. Allele bands 
shorter than 4bp, corresponding to the main allele, were 
considered as stutter bands and were excluded from chi-
merism calculations. Samples with more than 90% chime-
rism were classified as complete chimerism (100%Ch) and 
samples with less than 10% chimerism were classified as 
no chimerism (0%Ch).
TAble 2. Characteristics and percentage chimerism of different biological samples at different time intervals


















































1 M/11 M Thalassemia BMT  99.75 16.72 0  98.32 24.00 0  90.58 28.72  1.08
2 M/3 F CDA with thalassemia BMT 100 23.00 1.34 100 25.98 2.16 100 27.00  4.45
3 M/39 F AML PBSCT 100 12.3 0.56 100 15.4 1.21 100 18.3  2.00
4 M/18 F Severe aplastic anemia PBSCT 100 12.60 1.98 100 14.33 2.32 100 24.97  3.67
5 M/35 F Severe aplastic anemia PBSCT 100  9.2 0 100 10.1 0 100 11.3  0
6 M/11 M Aplastic anemia PBSCT 100 10.5 0 100 11.6 0.67 100 12.3  0.98
7 F/45 F Severe aplastic anemia PBSCT 100 15.9 2.38 100 16.4 2.62 100 19.2  3.54
8 M/8 F Thalassemia BMT 100 20.5 4.38 100 25.1 5.12 100 29.7  8.00
9 M/31 M Refractive pure RBC aplasia PBSCT 100  1.23 0 100  2.45 0 100  2.98  0
10 F/21 F Severe aplastic anemia PBSCT  92.4 20.09 0.49  96.41 24.7 1.33  97.5 32.00  9.50
11 M/35 F Severe aplastic anemia PBSCT 100 14.2 4.25 100 17.4 5.87 100 25.7  8.00
12 M/41 M Mixed phenotypic acute leukemia PBSCT 100  2.56 0 100  3.59 0 100  5.36  0.67
13 M/8 F Very severe aplastic anemia BMT  87 35.6 4.6  91 41.8 8.65  97  53.6  9,12
14 F/3 F Thalassemia BMT  54.6  1..5 0  55.1  2.86 0  57  4.00  0
15 M/21 F Very severe aplastic anemia PBSCT 100  6.73 0 100 10.6 0 100 12.3  0
16 M/15 M Severe aplastic anemia PBSCT  93 38.5 6.78  95 48.9 9.76  99 54.5 10.09
17 M/22 M Very severe aplastic anemia PBSCT 100  5.6 0 100  9.4 1.23 100 12.6  3.41
18 M/32 M CML PBSCT 100  7.54 0 100 10.7 0 100 11.2  0
19 M/28 F Severe aplastic anemia PBSCT  97 15.6 2.31  99 17.5 4.59 100 24.8  6.23
20 F/42 F Acute myeloid leukemia PBSCT 100 22.1 5.12 100 24.00 6.00 100 25.1  9.49
21 M/42 M Aplastic anemia PBSCT 100  2.56 0 100  5.34 0 100  7.8  0
22 M/8 F Thalassemia major BMT 100 10.4 0.23 100 12.6 1.98 100 15.5  2.00
23 F/39 M CML PBSCT 100 28.9 3.24 100 36.7 5.23 100 45.8  7.98
24 F/12 F Thalassemia major BMT  55.00  0.5 0  51.2  1.11 0  46.9  1.9  0
























*bMT – bone marrow transplantation; PbsCT – peripheral blood stem cell transplantation; CDA – congenital dyserythropoietic anemia ; AMl – acute myeloid leukemia; RbC 
– red blood cells.
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statistical analysis
Data are presented as mean and standard deviation. Wil-
coxon signed-rank test was used to compare the chi-
merism levels of different biological specimens at differ-
ent time intervals. Paired t test was used to compare the 
groups of three different biological samples, ie, blood, buc-
cal swab, hair follicle, collected at three different time in-
tervals (21-30 days, 90 days, and 180 days post transplant). 
P < 0.05 was considered as the significance level. AdaMSoft 
software was used for statistical analysis.
ResUlTs
19 blood samples showed complete donor chimerism 
(100%), 3 patients (unique patient number [UPN] 10, 16, 
19) showed chimerism within the range of 92.4%-100%, 
and other 3 patients (UPN 13, 14, 24) showed mixed chime-
rism within the range of 46.9%-97% at various time points 
(Table 2). Buccal swabs showed donor chimerism in all the 
samples at all time points. 8 showed donor chimerism be-
low 10% (UPN 9,12,14,15,17,18, 21, and 24). The majority of 
hair follicle samples showed donor chimerism (18 of 25), 
but in none chimerism was above 10%. Seven patients 
(UPN-5, 9, 14, 15, 18, 21, 24) showed no chimerism and re-
mained completely of recipient type. 3 patients (UPN 1, 6, 
12) showed donor chimerism below 1% and 15 patients 
showed donor chimerism below 10% at all the time inter-
vals (Figure 1,2; Table 3). There was a significant change in 
the percentage of donor chimerism among the groups of 
the biological samples (peripheral blood, buccal swab, hair 
follicle) in recipient samples at every time point analyzed 
post transplant (P = 0.0001). With time, gradual increase in 
the percentage of donor chimerism was observed. No cor-
relation of chimerism level with patients’ age and no corre-
lation between different groups of biological samples and 
donor chimerism and different time intervals post trans-
plant (P > 0.05) (Figure 1 and 2) was observed.
DisCUssion
A few cases of chimerism have been reported in forensic 
context but this is still an under-reported genetic pecu-
liarity (19). During the medico legal investigations this in-
formation is often not available. Our results suggest that 
all patients who had a history of allo-BMT/PBSCT showed 
TAble 3. Mean, standard deviation, and p50 value of peripheral 
blood, buccal swabs, and hair follicles at different time intervals 




Blood (+21-31 d) 95.15 12.554 100 (54.6-100)
Blood (+3 mo) 95.44 12.910 100 (51.2-100)
Blood (+6 mo) 95.51 13.341 100 (46.9-100)
Buccal swab (+21-31 d) 14.23 10.340 1 2.6 (0.5-38.5)
Buccal swab (+3 mo) 17.57 12.310  15.4 (1.11-48.9)
Buccal swab (+6 mo) 21.48 14.569  19.2 (1.9-54.5)
Hair follicle (+21-31 d)  1.53  2.040   0.49 (0-6.78)
Hair follicle (+3 mo)  2.46  2.869   1.33 (0-9.76)
Hair follicle (+6 mo)  3.83  3.698   3.41 (0-10.09)
FiGURe 1.  Percentage of donor chimerism in buccal swabs at 
different post transplant intervals in all the patients (n=25), 
P=0.001.
FiGURe 2.  Percentage of donor chimerism in hair follicle 
samples at different post transplant intervals in all the patients 
(n=25), P=0.001.
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complete donor profile in blood, with few exceptions and 
mixed chimerism in buccal swabs and hair follicles.
For all the hair samples, percentage of donor chimerism 
was between 0%-10% hence this could be classified as “no 
chimerism.” The small percentage of donor DNA observed 
in hair follicle samples could have been the result of con-
tamination with leukocytes because blood in traces could 
have come out along with hair follicle. Although proper 
care was taken to remove the possible contamination from 
the plucked hair follicle, the possibility of contamination 
cannot be ruled out completely. Also, the technique we 
used is very sensitive to such contamination; the sensitiv-
ity of Identifiler® kit is given in terms that full profile can be 
obtained from 2 ng down to 0.25 ng of human genomic 
DNA (Applied Biosystem, User manual).
The genotype of buccal swabs in all the patients showed 
donor chimerism. There are few possible explanations for 
the presence of high percentage of donor DNA in buccal 
swabs. During the collection of buccal swabs epithelial 
cells can be contaminated with saliva. Since granulocytes 
and lymphocytes are trafficking through the normal hu-
man mucosa and can be found in saliva, after successful 
transplantation these granulocytes and lymphocytes in 
recipient are derived from the donor. There is highly di-
vergent information on the number of leukocytes in the 
normal saliva, ranging from 2-136 000 cells/mL2 to 1.1 × 106 
cells/mL2 in a patient with inflammation of the oral cav-
ity (20). In order to remove as many non epithelial cells as 
possible from the buccal swab before collection, patients 
were asked to thoroughly rinse their mouth with water but 
still there was a possibility of mixing of leukocytes with epi-
thelial cells. Similarly, it was found that mouthwash sample 
of patients who underwent bone marrow transplant con-
tained high amount of donor DNA and was sometimes al-
most completely derived from the donor (7). Further, when 
epithelial cells were separated out from the mouthwash 
sample and analyzed for donor chimerism percentage, it 
was found that epithelial cells served as a good source to 
obtain recipient pre-transplant DNA profile (8). This study 
observed that 8 out of 25 patients showed lower per-
centage of donor chimerism (below 10%), while UPN 16 
showed high donor chimerism (54.5%). It is still not clear 
which factor defines the variable number of donor cells 
present in a buccal swab.
Jacewicz et al (15) found donor derived male DNA in the 
range of 0.96-19.16 ng/µL in epithelial cells of female re-
cipients who received allo-HSCT. According to them, the 
possible reason for the presence of donor chimerism is 
the “stem cell plasticity phenomenon” (21), ie, the ability of 
adult stem cells to cross lineage barrier and differentiate 
into cells outside their own tissue. Similarly, Berger et al (12) 
found donor DNA in every sample of buccal swab of adult 
recipients of allo-HCT and concluded that the presence of 
donor DNA in recipient buccal swab of such patients is a 
rule rather than the exception. They could not explain the 
biological cause of donor DNA presence in buccal epithelia 
of the recipient but believed it unlikely that it was caused 
by the migration of leukocytes in to the buccal epithelia as 
the collected buccal swab exclusively consisted of epithe-
lial cells with no contamination of saliva.
Various studies showed the presence of donor cells in dif-
ferent tissues of recipient’s body. Imanishi et al (13) dem-
onstrated the existence of donor cells in fingernails of 
recipients of allo-HCT transplant patients. Due to the my-
eloblative conditioning regimen of transplanted patients, 
their epithelial stem cells got damaged to a significant ex-
tent, which led to the transient growth retardation. This 
contributes to de-differentiation of donor hematopoietic 
stem cells into non-hematopoietic tissue of recipient.
After engraftment, production of donor cells from bone 
marrow in allo-transplanted recipients is an ongoing pro-
cess. These donor cells undergo their programmed death, 
apoptosis, and release donor DNA packaged into apop-
totic bodies (22-25). Although foreign DNA is normally 
cleared up (26), the excessive amount of released donor-
derived genetic material is horizontally transferred from 
apoptic hematopoietic cells to the cytoplasm and nucle-
us of epithelial cell lines through phagocytosis of apoptic 
bodies and is integrated within the recipient’s genome, re-
sulting in DNA chimerism (27). Furthermore, the incorpora-
tion of the foreign DNA into the host genome could result 
in physical rearrangement at the site of integration, includ-
ing point mutations, deletions, interruptions of coding se-
quence, and chromosomal breakages.
After allo-HSCT, epithelial tissues also become injured 
through preparative regimen and are then potentially at-
tacked by allo-reactive T cells. The net effect of this allo-
antigenic reaction is tissue stress and apoptosis, which is 
known as graft vs host disease. Chronic stress due to in-
teraction of donor derived lymphocytes with host epi-
thelium in the biological chimera may cause genomic al-
teration (28). Hence, the development of epithelial cells 
with donor derived genotype and the accumulation of 
genomic alterations in the epithelial tissue are the 
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recognized phenomena occurring in the recipient after al-
lo-HSCT, explaining the presence of donor derived DNA in 
recipient epithelial cells.
We observed a difference in donor chimerism among 
the individuals in all the three samples (blood, buccal 
swabs, and hair follicles) and interestingly every individu-
al showed difference in chimerism level at different post 
transplant intervals. The effect of post transplant intervals 
was also analyzed on the chimeric levels in every patient. 
With the increase in post transplant intervals, chimeric lev-
el increased in every patient but there was no significant 
co-relation between age and sex with chimerism percent-
age. The limitation of this study is that we performed fol-
low up of patients up to 180 days post transplant due to 
the time constraints.
In summary, blood and buccal swabs are not useful to 
get the patient’s pretransplant or true genotype profile as 
these samples are not devoid of donor derived cells. For 
hair samples, no donor chimerism was observed so they 
can be a reliable biological source for personal identifica-
tion using DNA profiling technique. Also, great care must 
be taken to avoid possible contamination while collecting 
the samples. The findings of this study are useful as sup-
portive data for forensic DNA profiling.
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